Annual Shareholders Equity
-$1.35 M
-$7.79 M-120.92%
01 December 2023
Summary:
Plus Therapeutics annual stockholders equity is currently -$1.35 million, with the most recent change of -$7.79 million (-120.92%) on 01 December 2023. During the last 3 years, it has fallen by -$4.38 million (-144.47%). PSTV annual shareholders equity is now -102.73% below its all-time high of $49.34 million, reached on 31 December 2000.PSTV Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
-$5.17 M
+$2.45 M+32.14%
01 September 2024
Summary:
Plus Therapeutics quarterly stockholders equity is currently -$5.17 million, with the most recent change of +$2.45 million (+32.14%) on 01 September 2024. Over the past year, it has dropped by -$3.83 million (-283.83%). PSTV quarterly shareholders equity is now -111.64% below its all-time high of $44.47 million, reached on 30 June 2001.PSTV Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTV Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -283.8% |
| 3 y3 years | -144.5% | -135.1% |
| 5 y5 years | -125.8% | -3333.8% |
PSTV Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -112.4% | at low | -135.1% | +32.1% |
| 5 y | 5 years | -112.4% | at low | -135.1% | +32.1% |
| alltime | all time | -102.7% | +87.5% | -111.6% | +77.7% |
Plus Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$5.17 M(-32.1%) |
| June 2024 | - | -$7.63 M(+57.6%) |
| Mar 2024 | - | -$4.84 M(+258.8%) |
| Dec 2023 | -$1.35 M(-120.9%) | -$1.35 M(-151.4%) |
| Sept 2023 | - | $2.62 M(-1.5%) |
| June 2023 | - | $2.66 M(-0.5%) |
| Mar 2023 | - | $2.68 M(-58.5%) |
| Dec 2022 | $6.45 M(-40.5%) | $6.45 M(-43.5%) |
| Sept 2022 | - | $11.40 M(+17.8%) |
| June 2022 | - | $9.68 M(-33.9%) |
| Mar 2022 | - | $14.64 M(+35.1%) |
| Dec 2021 | $10.84 M(+257.5%) | $10.84 M(-26.6%) |
| Sept 2021 | - | $14.76 M(+23.5%) |
| June 2021 | - | $11.95 M(+25.6%) |
| Mar 2021 | - | $9.51 M(+213.9%) |
| Dec 2020 | $3.03 M(+161.3%) | $3.03 M(+15.6%) |
| Sept 2020 | - | $2.62 M(-20.6%) |
| June 2020 | - | $3.30 M(+3782.4%) |
| Mar 2020 | - | $85.00 K(-92.7%) |
| Dec 2019 | $1.16 M(-77.8%) | $1.16 M(+625.0%) |
| Sept 2019 | - | $160.00 K(-102.5%) |
| June 2019 | - | -$6.28 M(-262.7%) |
| Mar 2019 | - | $3.86 M(-26.2%) |
| Dec 2018 | $5.22 M(-59.8%) | $5.22 M(-14.9%) |
| Sept 2018 | - | $6.14 M(+29.2%) |
| June 2018 | - | $4.75 M(-44.0%) |
| Mar 2018 | - | $8.48 M(-34.8%) |
| Dec 2017 | $13.00 M(+18.3%) | $13.00 M(+66.3%) |
| Sept 2017 | - | $7.82 M(-30.4%) |
| June 2017 | - | $11.23 M(+52.5%) |
| Mar 2017 | - | $7.36 M(-33.0%) |
| Dec 2016 | $10.99 M(-10.0%) | $10.99 M(-19.6%) |
| Sept 2016 | - | $13.67 M(-27.0%) |
| June 2016 | - | $18.72 M(+141.8%) |
| Mar 2016 | - | $7.74 M(-36.6%) |
| Dec 2015 | $12.21 M(-314.1%) | $12.21 M(+144.1%) |
| Sept 2015 | - | $5.00 M(+121.2%) |
| June 2015 | - | $2.26 M(-109.7%) |
| Mar 2015 | - | -$23.20 M(+306.8%) |
| Dec 2014 | -$5.70 M(-282.1%) | -$5.70 M(+73.2%) |
| Sept 2014 | - | -$3.29 M(-376.0%) |
| June 2014 | - | $1.19 M(-50.3%) |
| Mar 2014 | - | $2.40 M(-23.3%) |
| Dec 2013 | $3.13 M(-51.5%) | $3.13 M(-198.2%) |
| Sept 2013 | - | -$3.19 M(-352.4%) |
| June 2013 | - | $1.26 M(-46.7%) |
| Mar 2013 | - | $2.37 M(-63.3%) |
| Dec 2012 | $6.46 M | $6.46 M(-166.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | -$9.73 M(-1875.9%) |
| June 2012 | - | $548.00 K(-92.0%) |
| Mar 2012 | - | $6.85 M(-31.1%) |
| Dec 2011 | $9.95 M(-56.5%) | $9.95 M(-16.6%) |
| Sept 2011 | - | $11.93 M(+17.6%) |
| June 2011 | - | $10.14 M(-17.9%) |
| Mar 2011 | - | $12.36 M(-46.0%) |
| Dec 2010 | $22.87 M(-725.3%) | $22.87 M(+406.3%) |
| Sept 2010 | - | $4.52 M(-68.0%) |
| June 2010 | - | $14.10 M(+10.7%) |
| Mar 2010 | - | $12.74 M(-448.2%) |
| Dec 2009 | -$3.66 M(-52.6%) | -$3.66 M(+157.1%) |
| Sept 2009 | - | -$1.42 M(+61.7%) |
| June 2009 | - | -$880.00 K(-84.6%) |
| Mar 2009 | - | -$5.72 M(-25.8%) |
| Dec 2008 | -$7.72 M(-17.9%) | -$7.72 M(+233.6%) |
| Sept 2008 | - | -$2.31 M(-81.0%) |
| June 2008 | - | -$12.20 M(+10.2%) |
| Mar 2008 | - | -$11.06 M(+17.7%) |
| Dec 2007 | -$9.40 M(-13.1%) | -$9.40 M(-4049.6%) |
| Sept 2007 | - | $238.00 K(-94.7%) |
| June 2007 | - | $4.50 M(+272.5%) |
| Mar 2007 | - | $1.21 M(-111.2%) |
| Dec 2006 | -$10.81 M(+73.6%) | -$10.81 M(+8.6%) |
| Sept 2006 | - | -$9.96 M(-46.2%) |
| June 2006 | - | -$18.50 M(+49.3%) |
| Mar 2006 | - | -$12.39 M(+98.9%) |
| Dec 2005 | -$6.23 M(-148.5%) | -$6.23 M(-245.5%) |
| Sept 2005 | - | $4.28 M(-29.1%) |
| June 2005 | - | $6.04 M(-27.3%) |
| Mar 2005 | - | $8.31 M(-35.3%) |
| Dec 2004 | $12.83 M(-13.9%) | $12.83 M(-25.2%) |
| Sept 2004 | - | $17.16 M(+36.0%) |
| June 2004 | - | $12.62 M(-23.0%) |
| Mar 2004 | - | $16.39 M(+10.0%) |
| Dec 2003 | $14.91 M(-42.6%) | $14.91 M(-21.4%) |
| Sept 2003 | - | $18.97 M(-8.8%) |
| June 2003 | - | $20.80 M(-8.3%) |
| Mar 2003 | - | $22.69 M(-12.7%) |
| Dec 2002 | $26.00 M(-32.5%) | $26.00 M(-5.7%) |
| Sept 2002 | - | $27.58 M(-13.2%) |
| June 2002 | - | $31.76 M(-9.9%) |
| Mar 2002 | - | $35.25 M(-8.4%) |
| Dec 2001 | $38.49 M(-22.0%) | $38.49 M(-8.2%) |
| Sept 2001 | - | $41.90 M(-5.8%) |
| June 2001 | - | $44.47 M |
| Dec 2000 | $49.34 M(-902.6%) | - |
| Dec 1999 | -$6.15 M(-5791.7%) | - |
| Dec 1998 | $108.00 K | - |
FAQ
- What is Plus Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Plus Therapeutics?
- What is Plus Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Plus Therapeutics?
- What is Plus Therapeutics quarterly shareholders equity year-on-year change?
What is Plus Therapeutics annual stockholders equity?
The current annual shareholders equity of PSTV is -$1.35 M
What is the all time high annual shareholders equity for Plus Therapeutics?
Plus Therapeutics all-time high annual stockholders equity is $49.34 M
What is Plus Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of PSTV is -$5.17 M
What is the all time high quarterly shareholders equity for Plus Therapeutics?
Plus Therapeutics all-time high quarterly stockholders equity is $44.47 M
What is Plus Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, PSTV quarterly stockholders equity has changed by -$3.83 M (-283.83%)